Kuwait Antifungal Drugs Market Size & Outlook, 2026-2033

The antifungal drugs market in Kuwait is expected to reach a projected revenue of US$ 62.6 million by 2033. A compound annual growth rate of 5.1% is expected of Kuwait antifungal drugs market from 2026 to 2033.
Revenue, 2025 (US$M)
$42.2
Forecast, 2033 (US$M)
$62.6
CAGR, 2026 - 2033
5.1%
Report Coverage
Kuwait

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait antifungal drugs market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait antifungal drugs market highlights

  • The Kuwait antifungal drugs market generated a revenue of USD 42.2 million in 2025 and is expected to reach USD 62.6 million by 2033.
  • The Kuwait market is expected to grow at a CAGR of 5.1% from 2026 to 2033.
  • In terms of segment, azoles was the largest revenue generating drug class in 2025.
  • Echinocandins is the most lucrative drug class segment registering the fastest growth during the forecast period.


Antifungal drugs market data book summary

Market revenue in 2025USD 42.2 million
Market revenue in 2033USD 62.6 million
Growth rate5.1% (CAGR from 2026 to 2033)
Largest segmentAzoles
Fastest growing segmentEchinocandins
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAzoles, Echinocandins, Polyenes, Allylamines
Key market players worldwideNovartis AG ADR, Pfizer Inc, Bayer AG, Sanofi SA, Merck KGaA, Merck & Co Inc, GlaxoSmithKline, Abbott Laboratories, Enzon Pharmaceuticals Inc, Astellas Pharma Inc, Glenmark Pharmaceuticals


Other key industry trends

  • In terms of revenue, Kuwait accounted for 0.2% of the global antifungal drugs market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, Saudi Arabia antifungal drugs market is projected to lead the regional market in terms of revenue in 2033.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 394.1 million by 2033.

Azoles was the largest segment with a revenue share of 50.24% in 2025. Horizon Databook has segmented the Kuwait antifungal drugs market based on azoles, echinocandins, polyenes, allylamines covering the revenue growth of each sub-segment from 2021 to 2033.


Kuwait has an invasive aspergillosis prevalence rate of 16.7%. The prevalence of candidemia has an incidence rate of 6.8 per 100,000 . Oral candidiasis has a prevalence rate of 1.7 per 100,000. Recurrent Candida vaginitis (>4×/year) has a high incidence of 2,595 per 100,000.

Allergic bronchopulmonary aspergillosis (ABPA) has a prevalence rate of 187 per 100,000 in the population suffering from respiratory diseases. Some of the key market players operating in the market are SPIMACO and Jamjoom Pharma.

Kuwait Ministry of Health (MOH) is the regulatory authority operating in Kuwait. The registration of medicines was governed by Ministerial Decree No. 361 of 2019 ("Decree"), which was published by Kuwait's Ministry of Health ("MOH") in January 2020. The Decree updates the various MOH regulations regarding the registration of pharmaceutical items and enhances the legislation governing pharmacies.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Antifungal Drugs Market Companies

Name Profile # Employees HQ Website
Glenmark Pharmaceuticals View profile 10001+ Andheri, Maharashtra, India, Asia http://www.glenmarkpharma.com
GlaxoSmithKline View profile 10001+ London, England, United Kingdom, Europe http://www.gsk.com
Astellas Pharma Inc View profile 14484 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 http://www.astellas.com
Enzon Pharmaceuticals Inc View profile 1 20 Commerce Drive, Suite 135, Cranford, NJ, United States, 07016 http://www.enzon.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Kuwait antifungal drugs market size, by drug class, 2021-2033 (US$M)

Kuwait Antifungal Drugs Market Outlook Share, 2025 & 2033 (US$M)

Kuwait antifungal drugs market size, by drug class, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online